ChemoCentryx (CCXI) Reports In-Line Q4 EPS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/29/2026
- Nasdaq falls as Alphabet set for record loss amid AI spending woes
- Alphabet shares tumble 10% as earnings miss overshadows cloud boom
- Microsoft rises premarket as cloud strength drives earnings beat
- Caterpillar shares slump 10% despite earnings beat amid rapid AI buildout
- DoorDash to acquire Instacart in $17 billion deal
Tweet
Share
E-mailGet Alerts CCXI Hot Sheet
Join SI Premium – FREE
ChemoCentryx (NASDAQ: CCXI) reported Q4 EPS of ($0.28), in-line with the analyst estimate of ($0.28).
For earnings history and earnings-related data on ChemoCentryx (CCXI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Aon CEO warns AI data centers carry insurance risks
- Agility Robotics expands Digit robot customer base ahead of Nasdaq listing
- Kidoz names Derek Sentner as chief revenue officer
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
